Skip to main content

Year: 2021

Kirkland Lake Gold Announces Update to Fosterville News Release of August 30th, Significantly Increases Grade of Key Lower Phoenix Intercept

Figure 1Longitudinal Projection – Fosterville Gold MineFigure 2Longitudinal Projection – Swan/Lower Phoenix South MineralizationRevised underground drill assay result increases the grade of VG(1) intercept in hole UDH4051 located down-plunge of Swan Zone, 500 m(1) from deepest Mineral ReservesKey intercept: 51.7 g/t(1) over 2.6 m (ETW(1) 2.2 m) revised to 207 g/t(1) Au over 2.6 m(1) (ETW(1) 2.2 m(1))(1) Abbreviations include: VG – Visible Gold; m – metres; g/t – grams per tonne gold; ETW – estimated true width. TORONTO, Nov. 05, 2021 (GLOBE NEWSWIRE) — Kirkland Lake Gold Ltd. (“Kirkland Lake Gold” or the “Company”) (TSX:KL) (NYSE:KL) (ASX:KLA) today announced a revised drill intercept for one drill hole reported in the Lower Phoenix System at Fosterville in the news release issued on August...

Continue reading

MannKind Presents Data at 21st Annual Diabetes Technology Meeting

A Technosphere® Insulin (TI) dose – approximately double the estimated mealtime subcutaneously (SC) injection dose – reduced postprandial glucose excursions (PPGE) without any severe hypoglycemia in the first two hours Higher dose of TI resulted in approximately 50 mg/dL improvement in PPGE at 120 minutesWESTLAKE VILLAGE, Calif., Nov. 05, 2021 (GLOBE NEWSWIRE) —  MannKind Corporation (Nasdaq: MNKD), which focuses on the development of innovative medicines for patients with endocrine and orphan lung diseases, will present data at the 21st Annual Diabetes Technology Meeting. The data is currently available to meeting attendees and will be presented in an oral session November 11 by Dr. Kevin Kaiserman, Vice President of Medical Affairs and Safety of MannKind. Mealtime control of glucose for patients living with diabetes remains...

Continue reading

Nabriva Therapeutics to Present at the Jefferies London Healthcare Conference

DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 05, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that Ted Schroeder, Chief Executive Officer at Nabriva, will provide a company overview and business update at the Jefferies London Healthcare Conference. The presentation will be available on-demand beginning on Thursday, November 18 at 8:00am GMT / 3:00am ET through Friday, November 19 at 5:00pm GMT / 12:00pm ET. Management will host investor meetings on Thursday and Friday, November 18-19, 2021. The presentation may be accessed by visiting the “Investors” section of the Company’s website under the “Events and Presentations” tab...

Continue reading

Olink announces participation in November investor events

UPPSALA, Sweden, Nov. 05, 2021 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that it will be participating in two investor events in November. Olink virtual investor day with proteomics KOLsOn November 15th, 2021, from 12:30pm to 3:30pm ET (6:30pm to 9:30pm CET), Olink will host a virtual investor day, providing direct access to key opinion leaders from leading universities and BioPharma companies, discussing exciting research projects where Olink is a proud contributor, while also providing an overview of Olink’s commercial plans. Nordic Post IPO Seminar 2021Oskar Hjelm, CFO, will participate in the Nordic Post IPO Seminar 2021, on November 24th, from 4:00am to 4:45am ET (10:00am to 10:45 am CET) hosted by Handelsbanken Capital Markets. About Olink Olink Holding AB (Nasdaq: OLK) is a company...

Continue reading

Medaro Doubles Proposed Flow-Through Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Nov. 05, 2021 (GLOBE NEWSWIRE) — Medaro Mining Corp. (CSE: MEDA) (OTC: MEDAF) (FWB: 1ZY) (“Medaro” or the “Company”), a multi-faceted venture aimed at developing innovative spodumene processing technology concurrent with its clean-energy focused exploration on properties located across Canada, is pleased to announce, further to its previous announcement on November 3, 2021, an increase in the amount it intends to raise through its private placement (the “FT Financing”) of flow-through units (each, an “FT Unit”). Through the FT Financing, the Company now intends to issue up to 5,714,285 FT Units at a price of $0.70 per FT Unit for aggregate gross proceeds of up to $4,000,000. Each FT Unit will be composed of one...

Continue reading

Olink announces participation in November investor events

UPPSALA, Sweden, Nov. 05, 2021 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that it will be participating in two investor events in November. Olink virtual investor day with proteomics KOLsOn November 15th, 2021, from 12:30pm to 3:30pm ET (6:30pm to 9:30pm CET), Olink will host a virtual investor day, providing direct access to key opinion leaders from leading universities and BioPharma companies, discussing exciting research projects where Olink is a proud contributor, while also providing an overview of Olink’s commercial plans. Nordic Post IPO Seminar 2021Oskar Hjelm, CFO, will participate in the Nordic Post IPO Seminar 2021, on November 24th, from 4:00am to 4:45am ET (10:00am to 10:45 am CET) hosted by Handelsbanken Capital Markets. About Olink Olink Holding AB (Nasdaq: OLK) is a company...

Continue reading

Diversey Reports Third Quarter 2021 Results

FORT MILL, S.C., Nov. 05, 2021 (GLOBE NEWSWIRE) — Diversey Holdings, Ltd. (“Diversey”) (NASDAQ: DSEY) announced Q3 results with continued quarter-over-quarter top line growth and margin expansion. THIRD QUARTER HIGHLIGHTSReported Q3 net sales declined 2.4% vs 2020 as continued strength in Food & Beverage and encouraging base Institutional recovery was offset by infection prevention normalization off the increased level in Q3 2020, although infection prevention remains significantly above 2019 levels. Reported Q3 net sales nearly back to pre-COVID level with a decline of 0.4% vs 2019 baseline. Net loss of $42.1 million in Q3 versus $13.0 million net income in 2020 and $7.1 million net loss in pre-COVID 2019 Q3 Adjusted net income of $30.2 million versus $37.8 million in 2020 and $37.8 million in pre-COVID 2019 Adjusted...

Continue reading

Energy And Water Development Receives Global Trademark Protection for Their Name and Logo

Energy And Water DevelopmentEAWD-eAWG Type IISaint Petersburg, Florida, Nov. 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Energy And Water Development (EAWD) is pleased to announce the company’s filing for global trademark protection of their name and logo has been accepted. Once final official registered protection has been received, the company will ramp up marketing initiatives and introduce the company to a wider audience who can benefit from the company’s groundbreaking energy-supplied Atmosphere Water Generation systems (eAWG). This comes on the heels of the acceptance of their international patent application by the World Intellectual Property Organization (WIPO). A global alliance that ensures the protection of trademarks and patents, WIPO protects patents and trademarks in more than 150 countries...

Continue reading

KULR Technology Group Sets Third Quarter 2021 Earnings Call for Thursday, November 18, 2021 at 4:30 p.m. ET

SAN DIEGO, Nov. 05, 2021 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leading developer of next-generation lithium-ion battery safety and thermal management technologies, will hold a conference call on Thursday, November 18th at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the third quarter ended September 30, 2021. Financial results will be issued in a press release prior to the call. KULR management will host the presentation, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call at KULR@gatewayir.com by 8:00 PM ET on Monday, November 15, 2021. Questions will be addressed based on the relevance to the Company’s strategic direction and execution, shareholder...

Continue reading

TELUS reports operational and financial results for third quarter 2021

Industry-leading total mobile and fixed customer growth of 320,000, up 43,000 over last year, marking TELUS’ highest quarter ever Strong, high-quality mobile phone net additions of 135,000, a 24,000 increase over the prior year driven by industry-leading mobile phone churn; record connected device net additions of 110,000, up 23,000 year-over-year Robust wireline customer net additions of 75,000, powered by world-leading customer loyalty in combination with TELUS’ PureFibre network, including sustained momentum on accretive copper-to-fibre migrations as TELUS continues to successfully execute on its accelerated broadband expansion plan Continued strong operating momentum in TELUS International and TELUS Health, with double-double digit revenue growth driven by a combination of robust organic customer growth and acquisitions Consolidated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.